BA.2.38 has not led to any increase in hospitalisation, disease severity: Insacog bulletin https://ift.tt/IuUamh2

The Insacog reports genomic surveillance of SARS-CoV-2 across the country through sequencing of samples from sentinel sites and international passengers arriving in India. In its previous bulletin dated June 13, which was also released on Sunday, the Insacog said BA.2 continues to be the dominant lineage in India.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/KFjZRY6